Eduardo Angles-Cano

Prof. Dr. Eduardo Angles-Cano

Innovative Therapies in Haemostasis, Inserm, Paris, Île-de-France, France
+1
orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in The American Journal of Pathology
Verified
Journal Article
Closed access
VFVincent Fontaine
Vincent Fontaine
MJMarie-Paule Jacob
Marie-Paule Jacob
XHXavier Houard
Xavier Houard
PRPatrick Rossignol
Patrick Rossignol
DPDidier Plissonnier
Didier Plissonnier
JMJean-Baptiste Michel
Jean-Baptiste Michel

1 October 2007 in Blood
Verified
Journal Article
Open access
PDF file
RLRomaric Lacroix
Romaric Lacroix
FSFlorence Sabatier
Florence Sabatier
AMAgnès Mialhe
Agnès Mialhe
ABAgnès Basire
Agnès Basire
RPRalph Pannell
Ralph Pannell
FDFrançoise Dignat-George
Françoise Dignat-George
The regulation of plasmin generation on cell surfaces is of critical importance in the control of vascular homeostasis. Cell-derived microparticles participate in the dissemination of biological activities. However, their capacity to promote plasmin generation has not been documented. In this study, we show that endothelial microparticles (EMPs) from tumor necrosis factor α (TNFα)–stimulated endothelial cells served as a surface for the generation of plasmin. The generation of plasmin involved expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) at the surface of EMPs and was further increased by their ability to bind exogenous uPA on uPAR. Plasminogen was activated at the surface of EMPs in a dose-dependent, saturable, and specific manner as indicated by the inhibition of plasmin formation by ϵ-amino-caproic acid (ϵ-ACA) and carboxypeptidase B. EMP-induced plasmin generation affects tube formation mediated by endothelial progenitor cells. However, low amounts of EMPs increased tube formation, whereas higher concentrations inhibited it. Prevention of these effects by inhibitors of either uPA or plasmin underscore the key role of EMP-induced plasmin generation. In conclusion, we demonstrated that EMPs act as vectors supporting efficient plasmin generation and dissemination, a new pathway in the regulation of endothelial proteolytic activities with potential involvement in inflammation, angiogenesis, and atherosclerosis.

30 July 1991 in Biochemistry
Verified
Journal Article
Closed access
VFValerie Fleury
Valerie Fleury
EAEduardo Angles-Cano
Eduardo Angles-Cano

24 June 2012 in Haematologica
Verified
Journal Article
Open access
PDF file
RLR. Lacroix
R. Lacroix
LPL. Plawinski
L. Plawinski
SRS. Robert
S. Robert
LDL. Doeuvre
L. Doeuvre
FSF. Sabatier
F. Sabatier
FDF. Dignat-George
F. Dignat-George
Background We recently assigned a new fibrinolytic function to cell-derived microparticles in vitro. In this study we explored the relevance of this novel property of microparticles to the in vivo situation.Design and Methods Circulating microparticles were isolated from the plasma of patients with thrombotic thrombocytopenic purpura or cardiovascular disease and from healthy subjects. Microparticles were also obtained from purified human blood cell subpopulations. The plasminogen activators on microparticles were identified by flow cytometry and enzyme-linked immunosorbent assays; their capacity to generate plasmin was quantified with a chromogenic assay and their fibrinolytic activity was determined by zymography.Results Circulating microparticles isolated from patients generate a range of plasmin activity at their surface. This property was related to a variable content of urokinase-type plasminogen activator and/or tissue plasminogen activator. Using distinct microparticle subpopulations, we demonstrated that plasmin is generated on endothelial and leukocyte microparticles, but not on microparticles of platelet or erythrocyte origin. Leukocyte-derived microparticles bear urokinase-type plasminogen activator and its receptor whereas endothelial microparticles carry tissue plasminogen activator and tissue plasminogen activator/inhibitor complexes.Conclusions Endothelial and leukocyte microparticles, bearing respectively tissue plasminogen activator or urokinase-type plasminogen activator, support a part of the fibrinolytic activity in the circulation which is modulated in pathological settings. Awareness of this blood-borne fibrinolytic activity conveyed by microparticles provides a more comprehensive view of the role of microparticles in the hemostatic equilibrium.

29 June 2012 in Cell Death & Differentiation
Verified
Journal Article
Closed access
JPJ Parcq
J Parcq
TBT Bertrand
T Bertrand
AMA Montagne
A Montagne
ABA F Baron
A F Baron
RMR Macrez
R Macrez
DVDenis Vivien
Denis Vivien

8 May 2003 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
OMOlivier Meilhac
Olivier Meilhac
BHBenoît Ho-Tin-Noé
Benoît Ho-Tin-Noé
XHXavier Houard
Xavier Houard
MPMonique Philippe
Monique Philippe
JMJean-Baptiste Michel
Jean-Baptiste Michel
EAEduardo Angles-Cano
Eduardo Angles-Cano